Showing results (1731-1740 of 1,952) with videos related to

Sort By:
Pageof 196
Pilot and Feasibility Studies|November 11, 2022
The Women's Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trialNoreen Kearns, Laia Raigal-Aran, Kate O'Connell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancerShabnam Massah, Nicholas Pinette, Jane Foo, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Psychiatry Research|July 30, 2024
From mood to use: Using ecological momentary assessments to examine how anhedonia and depressed mood impact cannabis use in a depressed sampleAmanda C Collins, Damien Lekkas, Cara A Struble, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerGillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, et al.
Nature Communications|August 3, 2019
Large-scale neuroanatomical study uncovers 198 gene associations in mouse brain morphogenesisStephan C Collins, Anna Mikhaleva, Katarina Vrcelj, et al.
Implementation Science : IS|February 15, 2007
A quasi-experimental test of an intervention to increase the use of thiazide-based treatment regimens for people with hypertensionCarol M Ashton, Myrna M Khan, Michael L Johnson, et al.
Clinical Epigenetics|February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Cancer Research|March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate CancerXinpei Ci, Jun Hao, Xin Dong, et al.
Pageof 196